LeMaitre Vascular Inc (LMAT) stock analysis

P/E below its 5-year median

LeMaitre Vascular's P/E of 28.8 is below its own 5-year median of 44.9.

P/E above the industry

LeMaitre Vascular's P/E of 28.8 is above the Surgical, Medical, and Dental Instruments and Supplies median of 27.7.

EV/EBITDA below its 5-year median

LeMaitre Vascular's EV/EBITDA of 16.7 is below its 5-year median of 25.6.

P/B above the industry

LeMaitre Vascular's price-to-book of 4.20 is above the Surgical, Medical, and Dental Instruments and Supplies median of 3.22.

Trading below fair value

The share price of $79.29 is below our fair value estimate of $95.89.

Margin of safety under 20%

The price is 17.3% below fair value, less than the 20% cushion we look for.

Revenue growing 10%+ a year

Revenue grew 15.6% a year over the last three fiscal years.

EPS growing 10%+ a year

Diluted EPS grew 39.4% a year over the last three fiscal years.

Earnings growth not accelerating

Net income grew 18.7% over the last twelve months, against a 5-year average of 22.2% a year.

Growing faster than the industry

Revenue grew 11.8% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

Guidance lowered

LeMaitre Vascular lowered its Full Year Sales outlook on Aug 4, 2026.

Gross margin improving

Gross margin was 72.0% over the last twelve months, against 71.0% a year earlier.

Return on equity under 15%

Return on equity was 15.6% over the last twelve months and averaged 12.2% over five years; we look for 15% on both.

Return on capital over 10%

Return on invested capital was 148%, above the 10% that usually covers the cost of capital.

Return on equity above the industry

LeMaitre Vascular's return on equity of 15.6% is above the Surgical, Medical, and Dental Instruments and Supplies median of -31.3%.

Earnings grew over 5 years

Net income grew 22.2% a year on average over the last five fiscal years.

Net margin above its 5-year average

Net margin was 23.5% over the last twelve months, against a 5-year average of 17.8%.

Net margin above the industry

LeMaitre Vascular's net margin of 23.5% is above the Surgical, Medical, and Dental Instruments and Supplies median of -14.1%.

Debt level

Needs debt and equity figures.

Debt trend

Needs a balance sheet from five years ago with positive equity.

Debt coverage

Needs operating cash flow.

Interest well covered

Operating income covers interest expense 14.4 times.

Short-term assets cover short-term debts

Current assets are 14.60 times current liabilities.

Low bankruptcy risk

The Altman Z-score is 6.97; above 3 is the safe zone and below 1.8 the distress zone.

Pays a dividend

LeMaitre Vascular paid dividends worth 1.2% of the share price over the last twelve months.

Yield below Treasuries

The 1.2% yield is below the 4.4% on a 1-year Treasury.

Yield below the top quarter

The top quarter of US dividend payers yield 3.8% or more; LeMaitre Vascular yields 1.2%.

Dividend not cut

The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

Covered by earnings

Dividends take 34.2% of net income.

Covered by free cash flow

Dividends take 32.4% of free cash flow.